Thank you for highlighting the SEVERAL ways this differs from the Regenerative Science case that some try to claim is a preview as to what is to happen to USRM.
Our main supported arguments weren’t even arguments or standing points for Regenexx. With all the facts laid out, the only question is will this Judge be corrupt in her ruling or will she just stick to the facts both scientific and previous case law. At least it’s a woman judge so hopefully she sees the innovator that Kristin is.
And if NOT then like you said, Regenexx is still very much active and a player in the stem cell market even after losing their VERY DIFFERENT case against the FDA.
News 
Market Data 
Discover 
